132 related articles for article (PubMed ID: 38123348)
1. Rare myxoid pleomorphic liposarcoma: a case report and literature review.
Shen Y; Zhao L; Li A; Peng Q; Liu Q; Wang L; Liu Z
J Clin Pathol; 2024 Apr; 77(5):358-362. PubMed ID: 38123348
[TBL] [Abstract][Full Text] [Related]
2. Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma.
Creytens D; Folpe AL; Koelsche C; Mentzel T; Ferdinande L; van Gorp JM; Van der Linden M; Raman L; Menten B; Fritchie K; von Deimling A; Van Dorpe J; Flucke U
Mod Pathol; 2021 Nov; 34(11):2043-2049. PubMed ID: 34168281
[TBL] [Abstract][Full Text] [Related]
3. [Myxiod pleomorphic liposarcoma: a clinicopathological and molecular genetic analysis of six cases].
Zheng XC; Huang HJ; You J; Lin XY; Chen DR; Zhong D
Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):738-742. PubMed ID: 35922164
[No Abstract] [Full Text] [Related]
4. Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study.
Dermawan JK; Hwang S; Wexler L; Tap WD; Singer S; Vanderbilt CM; Antonescu CR
Mod Pathol; 2022 Nov; 35(11):1644-1655. PubMed ID: 35672466
[TBL] [Abstract][Full Text] [Related]
5. Recurrent Pleomorphic Myxoid Liposarcoma in a Patient With Li-Fraumeni Syndrome.
Zare SY; Leivo M; Fadare O
Int J Surg Pathol; 2020 Apr; 28(2):225-228. PubMed ID: 31559875
[TBL] [Abstract][Full Text] [Related]
6. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A
Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315
[TBL] [Abstract][Full Text] [Related]
7. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive genomic profiling of a unique liposarcoma arising in a patient with Li-Fraumeni syndrome and the novel detection of c-myc amplification: a case report.
Watanabe H; Fujishima F; Motoi T; Aoyama Y; Niihori T; Takahashi M; Umegaki S; Oishi H; Tada H; Ichinohasama R; Sasano H
Diagn Pathol; 2022 Dec; 17(1):93. PubMed ID: 36514176
[TBL] [Abstract][Full Text] [Related]
9. Spindle cell liposarcoma with a TRIO-TERT fusion transcript.
Suster DI; Deshpande V; Chebib I; Taylor MS; Mullen J; Bredella MA; Nielsen GP
Virchows Arch; 2019 Sep; 475(3):391-394. PubMed ID: 30793229
[TBL] [Abstract][Full Text] [Related]
10. [From cytogenetics to cytogenomics of adipose tissue tumors: 2. Malignant adipose tissue tumors].
Pedeutour F; Maire G; Sirvent N;
Bull Cancer; 2004 Apr; 91(4):317-23. PubMed ID: 15242313
[TBL] [Abstract][Full Text] [Related]
11. Myxoid liposarcoma with nuclear pleomorphism: a clinicopathological and molecular study.
Kojima N; Kubo T; Mori T; Satomi K; Matsushita Y; Iwata S; Yatabe Y; Ichimura K; Kawai A; Ichikawa H; Yoshida A
Virchows Arch; 2024 Jan; 484(1):71-81. PubMed ID: 37704823
[TBL] [Abstract][Full Text] [Related]
12. Myxoid liposarcoma with pleomorphic cells: Report of two cases with molecular confirmation of FUS gene rearrangements.
Uchihashi K; Matsuyama A; Nakayama M; Sakamoto A; Shiba E; Hisaoka M
Pathol Res Pract; 2016 Nov; 212(11):1067-1070. PubMed ID: 27515548
[TBL] [Abstract][Full Text] [Related]
13. Amplification of DNA damage-inducible transcript 3 (DDIT3) is associated with myxoid liposarcoma-like morphology and homologous lipoblastic differentiation in dedifferentiated liposarcoma.
Mantilla JG; Ricciotti RW; Chen EY; Liu YJ; Hoch BL
Mod Pathol; 2019 Apr; 32(4):585-592. PubMed ID: 30420727
[TBL] [Abstract][Full Text] [Related]
14. [Clinical value of fluorescence
Wang W; Li X; Liu P; Dong Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report.
Grifasi C; Calogero A; Carlomagno N; Campione S; D'Armiento FP; Renda A
World J Surg Oncol; 2013 Nov; 11():305. PubMed ID: 24279301
[TBL] [Abstract][Full Text] [Related]
16. Liposarcoma in children and young adults: a clinicopathologic and molecular study of 23 cases in one of the largest institutions of China.
Peng R; Li N; Lan T; Chen H; Du T; He X; Chen M; Xie Y; Zhang Z; Zhao W; Zhang H
Virchows Arch; 2021 Sep; 479(3):537-549. PubMed ID: 33738541
[TBL] [Abstract][Full Text] [Related]
17. p14(ARF) methylation is a common event in the pathogenesis and progression of myxoid and pleomorphic liposarcoma.
Davidović R; Sopta J; Mandušić V; Krajnović M; Stanojević M; Tulić G; Dimitrijević B
Med Oncol; 2013; 30(3):682. PubMed ID: 23918242
[TBL] [Abstract][Full Text] [Related]
18. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features.
Boland JM; Colby TV; Folpe AL
Am J Surg Pathol; 2012 Sep; 36(9):1395-403. PubMed ID: 22895273
[TBL] [Abstract][Full Text] [Related]
19. [Well-differentiated/dedifferentiated liposarcoma associated with myxoid-like morphology: a clinicopathological and molecular genetic characteristics analysis of 34 cases].
Xue S; Liu QY; Gou XN; Zhao YW; Cheng Q; Kong LF
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):168-173. PubMed ID: 38281785
[No Abstract] [Full Text] [Related]
20. Well-Differentiated Liposarcoma of the Hypopharynx Exhibiting Myxoid Liposarcoma-like Morphology with MDM2 and DDIT3 Co-Amplification.
Murshed KA; Abo Samra H; Ammar A
Head Neck Pathol; 2022 Mar; 16(1):288-293. PubMed ID: 34089125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]